Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 30:9:e59136.
doi: 10.7554/eLife.59136.

Neuropathogenesis of SARS-CoV-2 infection

Affiliations
Review

Neuropathogenesis of SARS-CoV-2 infection

Shumayila Khan et al. Elife. .

Abstract

The COVID-19 pandemic caused by the SARS-CoV-2 has recently emerged as a serious jolt to human life and economy. Initial knowledge established pulmonary complications as the chief symptom, however, the neurological aspect of the disease is also becoming increasingly evident. Emerging reports of encephalopathies and similar ailments with the detection of the virus in the CSF has elicited an urgent need for investigating the possibility of neuroinvasiveness of the virus, which cannot be ruled out given the expression of low levels of ACE2 receptors in the brain. Sensory impairments of the olfactory and gustatory systems have also been reported in a large proportion of the cases, indicating the involvement of the peripheral nervous system. Hence, the possibility of neurological damage caused by the virus demands immediate attention and investigation of the mechanisms involved, so as to customize the treatment of patients presenting with neurological complications.

Keywords: COVID-19; SARS-CoV-2; brain; epidemiology; global health; human; neurological disorder; neuroscience; neurotropic behaviour; stroke.

PubMed Disclaimer

Conflict of interest statement

SK, JG No competing interests declared

Figures

Figure 1.
Figure 1.. Schematic diagram showing the possible routes of neuroinvasiveness of SARS-CoV-2.

References

    1. Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, Glaser A, Elsayegh D. COVID-19 presenting as stroke. Brain, Behavior, and Immunity. 2020;87:115–119. doi: 10.1016/j.bbi.2020.04.077. - DOI - PMC - PubMed
    1. Beijing Ditan Hospital Capital medical university. [April 15, 2020];2020 http://www.bjdth.com/html/1/151/163/3665.html
    1. Bernard-Valnet R. Two patients with acute meningoencephalitis concomitantwith SARS-CoV-2 infection. European Journal of Neurology. 2020;2:14298. doi: 10.1111/ene.14298. - DOI - PMC - PubMed
    1. Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, Humphries F, Jäger HR, Losseff NA, Perry RJ, Shah S, Simister RJ, Turner D, Chandratheva A, Werring DJ. Characteristics of ischaemic stroke associated with COVID-19. Journal of Neurology, Neurosurgery & Psychiatry. 2020;91:889–891. doi: 10.1136/jnnp-2020-323586. - DOI - PMC - PubMed
    1. Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Revue Neurologique. 2020;176:516–518. doi: 10.1016/j.neurol.2020.04.003. - DOI - PMC - PubMed

Publication types

MeSH terms